Get all your news in one place.
100's of premium titles.
One app.
Start reading
Al Jazeera
Al Jazeera
Health

Ebola vaccines produced lasting antibodies during trial: Studies

The vaccines are designed to target the Zaire strain of the virus, which is the most lethal [File: Baz Ratner/Reuters]

Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies conducted in West Africa.

Both companies’ vaccines produced antibodies 14 days after the first of two shots and were detectable at varying levels in both children and adults for one year, data from the studies published on Wednesday showed.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.